Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Jamestown › NPI 1033227111
Physician

Upmc Chautauqua at Wca

Upmc Chautauqua at Wca was paid $38.77M by Medicaid between May 2018 and Nov 2024, across 372 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.

33Billing provider infoUPMC CHAUTAUQUA AT WCA
JAMESTOWN, NY 14701
33aNPI1033227111assigned 08/28/2006
33bProvider typeEmergency Medicine Physician
28Total paid$38.77M
24GClaims915,638
24DCodes billed372
24AFirst – last monthMay 2018 – Nov 2024
Compared with peers

Next to other Emergency Medicine Physician providers in New York

Rank by total paid#5 of 2,113
Median peer was paid$5K
This provider vs. median8,546×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018103,443$3.00M
2019155,829$4.72M
2020133,923$4.61M
2021135,099$5.16M
2022135,820$10.82M
2023141,051$6.79M
2024incomplete110,473$3.67M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 24,366 22,795 $4.01M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.4% 26,863 24,480 $3.64M
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 8.3% 24,962 17,361 $3.22M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.7% 26,621 21,432 $2.21M
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient 4.1% 9,787 7,025 $1.59M
36415 Collection of venous blood by venipuncture 3.9% 46,087 38,780 $1.52M
70450 Computed tomography, head or brain; without contrast material 3.5% 4,302 4,194 $1.35M
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation 3.4% 6,796 5,599 $1.30M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 3.1% 2,063 2,049 $1.22M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 8,879 8,433 $984K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.5% 2,009 1,998 $956K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.3% 3,635 3,558 $891K
360 more codes
80053 Comprehensive metabolic panel 1.9% 36,807 $735K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.9% 10,053 $725K
88342 1.8% 2,414 $715K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.8% 2,748 $707K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.6% 3,258 $632K
96361 Intravenous infusion, hydration; each additional hour 1.6% 2,920 $604K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.5% 7,313 $580K
99214 Doctor's office visit, returning patient (more involved) 1.3% 5,738 $506K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.2% 4,544 $476K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 3,215 $467K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 8,104 $460K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 416 $378K
80048 Basic metabolic panel (calcium, ionized) <1% 14,282 $330K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 13,110 $321K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,599 $319K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 21,759 $308K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,579 $295K
12001 <1% 473 $278K
59025 Fetal non-stress test <1% 1,899 $259K
93017 <1% 940 $231K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 10,978 $231K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,838 $220K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 5,907 $215K
71275 Computed tomographic angiography, chest, with contrast material <1% 718 $215K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,700 $207K
99203 Doctor's office visit, new patient (routine) <1% 1,510 $207K
97162 <1% 1,190 $184K
90853 Group psychotherapy (other than of a multiple-family group) <1% 3,189 $172K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 5,400 $171K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,064 $164K
97010 <1% 2,644 $155K
Q3014 Telehealth originating site facility fee <1% 3,609 $152K
99232 Hospital visit by a doctor, follow-up day <1% 5,154 $118K
76830 Ultrasound, transvaginal <1% 2,914 $116K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,672 $101K
80061 Lipid panel <1% 14,908 $93K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 282 $92K
97161 <1% 899 $91K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,059 $88K
83036 Hemoglobin; glycosylated (A1C) <1% 9,285 $88K
H0001 Alcohol and/or drug assessment <1% 619 $87K
84443 Thyroid stimulating hormone (TSH) <1% 9,410 $75K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,968 $72K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,488 $72K
87086 Culture, bacterial; quantitative colony count, urine <1% 16,420 $71K
99238 Hospital discharge day management, 30 minutes or less <1% 1,729 $64K
H0038 Self-help/peer services, per 15 minutes <1% 1,150 $64K
83880 <1% 2,177 $64K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 45,836 $62K
90837 Psychotherapy session, about an hour <1% 474 $61K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,044 $55K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 243 $51K
86850 <1% 2,451 $51K
84439 <1% 6,443 $51K
82607 <1% 3,962 $47K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,683 $46K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 770 $46K
99223 Prolong inpt eval add15 m <1% 694 $45K
12002 <1% 70 $44K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 456 $44K
99460 <1% 717 $43K
11721 <1% 168 $42K
71046 Radiologic examination, chest; 2 views <1% 8,751 $42K
82570 <1% 12,824 $41K
86901 <1% 2,616 $41K
84153 <1% 2,089 $40K
87510 <1% 2,924 $39K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes <1% 377 $36K
86900 <1% 2,607 $36K
86701 <1% 3,758 $35K
90715 <1% 1,287 $35K
82728 <1% 2,707 $35K
93225 <1% 473 $34K
70551 Magnetic resonance imaging, brain; without contrast material <1% 105 $34K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,034 $32K
87077 <1% 5,402 $32K
84702 <1% 4,167 $31K
80076 <1% 3,080 $31K
93320 <1% 38 $30K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,640 $30K
86803 <1% 3,036 $30K
83655 <1% 2,259 $30K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 277 $29K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 883 $28K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 323 $28K
82746 <1% 2,417 $28K
G0378 Hospital observation service, per hour <1% 3,254 $27K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,703 $27K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk <1% 13 $27K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 44 $27K
93971 <1% 582 $27K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 852 $27K
72125 Computed tomography, cervical spine; without contrast material <1% 1,302 $26K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,056 $26K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 55 $25K
87070 <1% 3,954 $25K
87040 <1% 3,818 $24K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 80 $24K
94060 <1% 386 $24K
81001 <1% 15,715 $23K
87186 <1% 5,123 $22K
97014 <1% 1,055 $21K
70486 <1% 449 $20K
95811 <1% 31 $20K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 918 $19K
87653 <1% 878 $19K
88304 <1% 665 $18K
99204 Doctor's office visit, new patient (more involved) <1% 198 $18K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 27 $18K
76801 <1% 387 $18K
H0005 Alcohol and/or drug services; group counseling by a clinician <1% 337 $18K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,054 $18K
76536 <1% 905 $17K
84403 <1% 652 $17K
84146 <1% 1,112 $17K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,327 $16K
87425 <1% 1,938 $16K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 487 $15K
73564 <1% 1,953 $15K
73630 <1% 3,302 $15K
99442 <1% 528 $14K
76819 Fetal biophysical profile; without non-stress testing <1% 161 $13K
88307 <1% 12 $13K
94726 <1% 463 $13K
81003 <1% 17,356 $13K
83540 <1% 2,693 $12K
71250 <1% 152 $12K
90847 Family psychotherapy with the patient present, 50 minutes <1% 67 $12K
83970 <1% 271 $12K
88312 <1% 1,045 $12K
85610 <1% 9,796 $12K
85730 <1% 5,594 $12K
87660 <1% 810 $11K
83735 <1% 5,743 $11K
85027 <1% 3,886 $11K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 57 $11K
72110 <1% 697 $11K
74018 <1% 2,314 $11K
77065 Tomosynthesis, mammo <1% 179 $11K
87420 <1% 523 $10K
82803 <1% 636 $10K
82043 <1% 1,994 $10K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 12 $10K
86706 <1% 696 $10K
87522 Neg quan hep c or qual rna <1% 195 $10K
87480 <1% 811 $9K
83550 <1% 2,068 $9K
76642 <1% 506 $9K
73030 <1% 1,813 $9K
72100 <1% 1,416 $9K
82784 <1% 725 $9K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 12 $8K
81025 <1% 2,611 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 370 $8K
80348 <1% 1,592 $8K
71271 <1% 265 $8K
86140 <1% 2,421 $8K
76775 <1% 186 $8K
73130 <1% 2,247 $7K
71045 Radiologic examination, chest; single view <1% 8,891 $7K
73610 <1% 2,288 $7K
85379 <1% 1,165 $7K
94729 <1% 285 $7K
12011 <1% 24 $7K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 515 $7K
77066 Tomosynthesis, mammo <1% 139 $7K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 333 $6K
73110 <1% 1,683 $6K
84100 <1% 1,681 $6K
84402 <1% 233 $6K
86592 <1% 1,838 $6K
54150 <1% 83 $6K
83690 <1% 8,865 $5K
92567 <1% 337 $5K
86038 <1% 1,076 $5K
72141 <1% 13 $5K
82950 <1% 1,048 $5K
76641 <1% 283 $5K
85651 <1% 3,066 $5K
29125 <1% 25 $5K
86762 <1% 314 $5K
86705 <1% 477 $5K
99443 <1% 362 $5K
87340 <1% 453 $5K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 313 $5K
80349 <1% 894 $4K
82977 <1% 839 $4K
10060 <1% 14 $4K
87205 <1% 1,995 $4K
83001 <1% 201 $4K
92557 <1% 112 $4K
86480 <1% 75 $4K
70496 <1% 12 $4K
74178 <1% 36 $3K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 102 $3K
76870 <1% 68 $3K
99239 Hospital discharge day management, more than 30 minutes <1% 40 $3K
80329 <1% 226 $3K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 96 $3K
86003 <1% 41 $3K
87427 <1% 257 $3K
J2785 Injection, regadenoson, 0.1 mg <1% 40 $3K
82150 <1% 1,635 $3K
82951 <1% 370 $3K
73502 <1% 562 $3K
93226 <1% 38 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 44 $2K
84156 <1% 784 $2K
83525 <1% 229 $2K
84481 <1% 284 $2K
84466 <1% 195 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 38 $2K
84484 <1% 7,966 $2K
83615 <1% 569 $2K
86709 <1% 209 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 771 $2K
86618 <1% 132 $2K
84460 <1% 361 $2K
99215 Doctor's office visit, returning patient (complex) <1% 17 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 67 $1K
86364 <1% 212 $1K
99222 Initial hospital care, per day, moderate complexity <1% 29 $1K
80324 <1% 274 $1K
99219 <1% 16 $1K
87328 <1% 121 $1K
73562 <1% 401 $1K
87329 <1% 122 $1K
81329 <1% 14 $1K
80353 <1% 276 $1K
82550 <1% 1,133 $1K
82105 <1% 208 $1K
84703 <1% 2,013 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 14 $1K
86431 <1% 231 $1K
80361 <1% 227 $1K
73080 <1% 310 $1K
87081 <1% 216 $1K
97166 <1% 12 $1K
82248 <1% 233 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 2,266 $1K
87177 <1% 118 $1K
80074 <1% 20 $964.33
84436 <1% 167 $963.20
87045 <1% 151 $888.35
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 275 $868.48
88142 <1% 38 $863.62
72040 <1% 102 $816.96
87015 <1% 264 $751.00
87449 <1% 2,779 $749.13
84450 <1% 157 $733.54
T1023 Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter <1% 15 $732.96
76813 <1% 24 $725.40
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,961 $721.30
87046 <1% 233 $702.10
93325 <1% 38 $668.91
82947 <1% 148 $655.50
92587 <1% 13 $600.00
H0004 Behavioral health counseling and therapy, per 15 minutes <1% 14 $598.24
73090 <1% 185 $594.72
72050 <1% 54 $580.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 585 $551.14
87209 <1% 80 $518.62
83605 <1% 3,377 $499.98
84550 <1% 139 $491.85
88112 <1% 15 $448.32
99462 <1% 14 $441.62
S0028 Injection, famotidine, 20 mg <1% 979 $435.91
72070 <1% 53 $381.81
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,124 $359.20
87324 <1% 54 $358.82
86376 <1% 24 $349.20
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 336 $316.61
73590 <1% 99 $308.85
86141 <1% 54 $301.72
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,159 $290.00
73140 <1% 140 $270.00
J7030 Infusion, normal saline solution , 1000 cc <1% 10,904 $242.33
86308 <1% 279 $241.58
84144 <1% 12 $229.46
77062 <1% 13 $215.41
80320 <1% 709 $189.90
73521 <1% 27 $180.50
82785 <1% 12 $149.79
82274 <1% 71 $149.60
81015 <1% 229 $136.04
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,389 $123.72
80354 <1% 1,183 $117.76
86255 <1% 12 $114.40
86231 <1% 15 $109.80
84165 <1% 13 $104.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,022 $103.93
86787 <1% 12 $97.32
95806 <1% 107 $94.19
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,261 $87.99
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,822 $82.50
82962 <1% 2,685 $80.97
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,032 $78.55
82948 <1% 380 $76.51
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,662 $74.01
86735 <1% 12 $72.27
82465 <1% 12 $60.36
73100 <1% 13 $60.00
83721 <1% 12 $56.32
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,212 $53.61
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,924 $48.79
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,962 $46.76
82553 <1% 440 $40.25
81002 <1% 30 $34.04
J1170 Injection, hydromorphone, up to 4 mg <1% 3,268 $30.70
J7060 5% dextrose/water (500 ml = 1 unit) <1% 297 $26.25
82010 <1% 620 $15.31
73552 <1% 12 $11.74
83789 <1% 160 $10.75
71101 <1% 12 $10.50
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,179 $10.49
J1815 Injection, insulin, per 5 units <1% 64 $9.96
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,662 $9.22
J2270 Injection, morphine sulfate, up to 10 mg <1% 929 $7.86
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 1,992 $5.98
83986 <1% 159 $3.34
J2060 Injection, lorazepam, 2 mg <1% 804 $2.14
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,053 $1.80
94760 <1% 447 $1.56
J1630 Injection, haloperidol, up to 5 mg <1% 190 $1.38
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 12 $0.12
87400 0% 1,229 $0.00
00811 0% 418 $0.00
00731 0% 1,456 $0.00
90785 0% 216 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 1,091 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 13 $0.00
00812 0% 85 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 107 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 57 $0.00
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 0% 12 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 202 $0.00
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 0% 14 $0.00
88313 0% 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 120 $0.00
A4649 Surgical supply; miscellaneous 0% 13 $0.00
A4314 Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) 0% 12 $0.00
A4565 Slings 0% 24 $0.00
A6234 Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 0% 12 $0.00
96375 Therapeutic injection; each additional sequential IV push 0% 8,881 $0.00
01922 0% 151 $0.00
96376 0% 2,779 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 88 $0.00
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 0% 12,452 $0.00
J7999 Compounded drug, not otherwise classified 0% 165 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 165 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 255 $0.00
C9399 Unclassified drugs or biologicals 0% 292 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 137 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 165 $0.00
A4351 Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each 0% 119 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 37 $0.00
97802 0% 27 $0.00
73600 0% 12 $0.00
C1769 Guide wire 0% 13 $0.00
J3490 Unclassified drugs 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDURNIOK, BRIAN (CEO)